HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evidence for the multimeric structure of ferroportin.

Abstract
Ferroportin (Fpn) (IREG1, SLC40A1, MTP1) is an iron transporter, and mutations in Fpn result in a genetically dominant form of iron overload disease. Previously, we demonstrated that Fpn is a multimer and that mutations in Fpn are dominant negative. Other studies have suggested that Fpn is not a multimer and that overexpression or epitope tags might affect the localization, topology, or multimerization of Fpn. We generated wild-type Fpn with 3 different epitopes, GFP, FLAG, and c-myc, and expressed these constructs in cultured cells. Co-expression of any 2 different epitope-tagged proteins in the same cell resulted in their quantitative coimmunoprecipitation. Treatment of Fpn-GFP/Fpn-FLAG-expressing cells with crosslinking reagents resulted in the crosslinking of Fpn-GFP and Fpn-FLAG. Western analysis of rat glioma C6 cells or mouse bone marrow macrophages exposed to crosslinking reagents showed that endogenous Fpn is a dimer. These results support the hypothesis that the dominant inheritance of Fpn-iron overload disease is due to the dominant-negative effects of mutant Fpn proteins.
AuthorsIvana De Domenico, Diane McVey Ward, Giovanni Musci, Jerry Kaplan
JournalBlood (Blood) Vol. 109 Issue 5 Pg. 2205-9 (Mar 01 2007) ISSN: 0006-4971 [Print] United States
PMID17077321 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Cation Transport Proteins
  • Epitopes
  • metal transporting protein 1
Topics
  • Animals
  • Cation Transport Proteins (genetics, immunology, metabolism)
  • Cell Line
  • Epitopes (immunology)
  • Humans
  • Mice
  • Protein Binding
  • Rats

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: